In vitro Azole antifungals susceptibility of Candida spp. isolates from HIV-infected patients with periodontitis
- 4 May 2022
- journal article
- research article
- Published by Elsevier in Journal of Medical Mycology
- Vol. 32 (3) , 101294
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund
- Ministerio de Economía y Competitividad
- Instituto de Salud Carlos III
This publication has 22 references indexed in Scilit:
- Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and CameroonDiagnostic Microbiology and Infectious Disease, 2014
- World Medical Association Declaration of HelsinkiJAMA, 2013
- New antimicrobial therapies used against fungi present in subgingival sites—A brief reviewArchives of Oral Biology, 2011
- A study of antifungal drug sensitivity of Candida isolated from human immunodeficiency virus infected patients in Chennai, South IndiaJournal of Oral and Maxillofacial Pathology, 2011
- Microbial shift and periodontitisPeriodontology 2000, 2010
- Bacterial Extracellular Polysaccharides Involved in Biofilm FormationMolecules, 2009
- In vitro susceptibility of oral Candida to seven antifungal agentsOral Microbiology and Immunology, 2005
- Development of a Classification System for Periodontal Diseases and ConditionsAnnals of Periodontology, 1999
- Emergence of azole drug resistance in Candida species from HIV-infected patients receivingprolonged fluconazole therapy for oral candidosisJournal of Antimicrobial Chemotherapy, 1995
- Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype AnalysisClinical Infectious Diseases, 1994